This page shows the latest Emerging Companies news and features for those working in and with pharma, biotech and healthcare.
The selected companies will receive up to 100, 000 in financial assistance, as well as mentoring from Merck. ... This is not the first time the company has offered support for emerging start-up companies in China.
The two companies plan to collaborate on the ‘next phase’ of bluebird bio's spin-off oncology cell therapy company 2seventy’s pipeline. ... The two companies are also planning to collaborate on the ‘next phase’ of 2seventy’s pipeline, and
to circulating and potential newly emerging SARS-CoV-2 variants. ... The companies also announced that they are planning a study to evaluate a variant-specific vaccine, using a new construct of their jab based on the B.1.351 variant first
New company is focused on financing biotech companies and new ventures in Europe working on the microbiome and synthetic biology. ... The new company, which is focusing on financing and building biotech companies in Europe in these emerging research
The companies are also in ongoing discussions with regulatory authorities regarding a clinical study to evaluate a variant-specific vaccine that would have a modified mRNA sequence. ... This study would use a new construction of the Pfizer/BioNTech
A number of vaccine makers are working on modified vaccines to address new and emerging variants. ... This study would use a new construction of the Pfizer/BioNTech vaccine based on the B.1.351 variant, according to the companies.
More from news
Approximately 0 fully matching, plus 57 partially matching documents found.
By Jill Condello. The Medical Affairs function within pharmaceutical, biotechnology and medical device companies has been on an accelerated evolutionary trajectory in recent years. ... at emerging biotechnology companies, a platform technology.
This ‘speed chess’ approach could be a winning strategy for emerging biopharma companies (EBCs). ... Twitter has evolved and these smaller companies will have a bigger appetite for it.
However, in addition to these internal drivers to improve agility, several external trends are also emerging. ... However, during our work with pharmaceutical companies launching products in rare diseases, one key characteristic stands out.
traditional pharmaceutical companies look to increase innovation is through bolt-on acquisitions of more innovative players in the industry. ... As we see with Takeda – and as we’ve seen with other industries, notably tech – companies from fast-
China has long been an alluring country for global pharma companies whose mature investments are now being layered with a new wave of partnerships. ... China is still strong in chemistry and Me-Better drugs but there is a whole new generation of
More from intelligence
Approximately 2 fully matching, plus 15 partially matching documents found.
In her new role, Anbar will lead the company’s partnership with clients ranging from major biopharmaceutical companies to emerging biotech, tech and health data pioneers, as well as patient advocacy ... In those roles, she led award-winning work for a
chairman of its Board of Directors. She has nearly 30 years of experience in the biotech industry as a leader of emerging companies. ... Katrine’s experience building dynamic, science-driven companies will serve as a critical resource for Arrakis as we
pipeline. Rothera brings 28 years’ experience in the biopharmaceutical industry including driving the transition of multiple emerging biotechnology companies from R&D stage to commercialisation, bringing rare disease therapies to the
His experience and judgement will be a tremendous asset to Arix Bioscience as we continue to support emerging and innovative companies globally.
Aurinia's chair Dr Richard Glickman said: “Stephen is a seasoned leader with a strong track record of delivering strategic direction and operational excellence to both established and emerging life sciences ... companies. “He is exceptionally
More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.
payers. With a broad client base of blue-chip pharmaceutical manufacturers and emerging biotechnology companies, Genesis Research is an established leader and one of the largest operators within a highly fragmented ... sciences companies to quickly and
industry. Two Labs helps pharmaceutical companies develop and execute customized launch strategies for products. ... Excellere Partners, a US-based private equity firm focused on partnering with entrepreneurs and management teams in emerging growth
We’ve developed and delivered brands, collateral, digital assets and engaging campaigns for emerging companies and global institutions, which have universally engaged healthcare professionals, patients, regulatory bodies, investors, and the press.
This skills shortage is a major challenge for the sector. Currently, the number of biotech companies emerging is growing much faster than the talent pool. ... society. “We look at the manufacturing challenges we are facing for emerging healthcare
Seizing the opportunities in a new era of care. In recent decades, emerging technologies have repeatedly forced smart companies to answer the question: what’s new here and what’s our ... Today, smart pharma companies should be asking that same
More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.
We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...